<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on 16 November 2026 at 07:36 by All in One SEO v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://pharmaguidelines.co.uk/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmaguidelines</title>
		<link><![CDATA[https://pharmaguidelines.co.uk]]></link>
		<description><![CDATA[Pharmaguidelines]]></description>
		<lastBuildDate><![CDATA[Mon, 16 Nov 2026 03:09:10 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://pharmaguidelines.co.uk/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/batch-record-reconciliation-yield-labels-and-material-accountability/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/batch-record-reconciliation-yield-labels-and-material-accountability/]]></link>
			<title>Batch Record Reconciliation: Yield, Labels and Material Accountability</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:09:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/gmp-training-effectiveness-beyond-attendance-records/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/gmp-training-effectiveness-beyond-attendance-records/]]></link>
			<title>GMP Training Effectiveness: Beyond Attendance Records</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:09:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/riskbased-supplier-qualification-for-pharmaceutical-raw-materials/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/riskbased-supplier-qualification-for-pharmaceutical-raw-materials/]]></link>
			<title>Risk-Based Supplier Qualification for Pharmaceutical Raw Materials</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:09:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capa-effectiveness-checks-evidence-metrics-and-timing/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capa-effectiveness-checks-evidence-metrics-and-timing/]]></link>
			<title>CAPA Effectiveness Checks: Evidence, Metrics and Timing</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:09:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/deviation-root-cause-analysis-five-whys-versus-fishbone/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/deviation-root-cause-analysis-five-whys-versus-fishbone/]]></link>
			<title>Deviation Root Cause Analysis: Five Whys Versus Fishbone</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/temperature-excursions-in-stability-chambers-product-impact-assessment/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/temperature-excursions-in-stability-chambers-product-impact-assessment/]]></link>
			<title>Temperature Excursions in Stability Chambers: Product Impact Assessment</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/outoftrend-results-in-stability-studies-investigation-workflow/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/outoftrend-results-in-stability-studies-investigation-workflow/]]></link>
			<title>Out-of-Trend Results in Stability Studies: Investigation Workflow</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-column-qualification-and-lifecycle-management/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-column-qualification-and-lifecycle-management/]]></link>
			<title>HPLC Column Qualification and Lifecycle Management</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-carryover-testing-blank-injections-and-acceptance-criteria/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-carryover-testing-blank-injections-and-acceptance-criteria/]]></link>
			<title>HPLC Carryover Testing: Blank Injections and Acceptance Criteria</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/karl-fischer-moisture-testing-blank-correction-and-drift-control/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/karl-fischer-moisture-testing-blank-correction-and-drift-control/]]></link>
			<title>Karl Fischer Moisture Testing: Blank Correction and Drift Control</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/oos-laboratory-investigation-phase-one-assessment-and-evidence/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/oos-laboratory-investigation-phase-one-assessment-and-evidence/]]></link>
			<title>OOS Laboratory Investigation: Phase One Assessment and Evidence</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-peak-tailing-causes-troubleshooting-and-gmp-documentation/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hplc-peak-tailing-causes-troubleshooting-and-gmp-documentation/]]></link>
			<title>HPLC Peak Tailing: Causes, Troubleshooting and GMP Documentation</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:08:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/document-control-in-gmp-effective-dates-and-obsolete-copies/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/document-control-in-gmp-effective-dates-and-obsolete-copies/]]></link>
			<title>Document Control in GMP: Effective Dates and Obsolete Copies</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:03:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/internal-gmp-audit-findings-classification-and-followup/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/internal-gmp-audit-findings-classification-and-followup/]]></link>
			<title>Internal GMP Audit Findings: Classification and Follow-Up</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:03:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/change-control-classification-minor-and-major-gmp-changes/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/change-control-classification-minor-and-major-gmp-changes/]]></link>
			<title>Change Control Classification: Minor and Major GMP Changes</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:03:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/management-review-in-pharmaceutical-quality-systems/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/management-review-in-pharmaceutical-quality-systems/]]></link>
			<title>Management Review in Pharmaceutical Quality Systems</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:03:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capa-prioritisation-risk-recurrence-and-effectiveness/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capa-prioritisation-risk-recurrence-and-effectiveness/]]></link>
			<title>CAPA Prioritisation: Risk, Recurrence and Effectiveness</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:03:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/deviation-trending-recurrence-and-systemic-signals/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/deviation-trending-recurrence-and-systemic-signals/]]></link>
			<title>Deviation Trending: Recurrence and Systemic Signals</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:02:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/product-recall-mock-exercise-traceability-and-effectiveness/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/product-recall-mock-exercise-traceability-and-effectiveness/]]></link>
			<title>Product Recall Mock Exercise: Traceability and Effectiveness</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:02:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/product-complaint-investigation-retains-and-batch-history/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/product-complaint-investigation-retains-and-batch-history/]]></link>
			<title>Product Complaint Investigation: Retains and Batch History</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:02:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/supplier-audit-planning-riskbased-frequency-and-scope/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/supplier-audit-planning-riskbased-frequency-and-scope/]]></link>
			<title>Supplier Audit Planning: Risk-Based Frequency and Scope</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:02:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/quality-agreement-with-contract-manufacturers-roles-and-escalation/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/quality-agreement-with-contract-manufacturers-roles-and-escalation/]]></link>
			<title>Quality Agreement With Contract Manufacturers: Roles and Escalation</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:02:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/manufacturing-yield-reconciliation-theoretical-and-actual-yield/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/manufacturing-yield-reconciliation-theoretical-and-actual-yield/]]></link>
			<title>Manufacturing Yield Reconciliation: Theoretical and Actual Yield</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hold-time-studies-for-bulk-pharmaceutical-products/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/hold-time-studies-for-bulk-pharmaceutical-products/]]></link>
			<title>Hold Time Studies for Bulk Pharmaceutical Products</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/powder-segregation-during-transfer-risk-assessment/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/powder-segregation-during-transfer-risk-assessment/]]></link>
			<title>Powder Segregation During Transfer: Risk Assessment</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capsule-fill-weight-variation-root-causes-and-monitoring/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/capsule-fill-weight-variation-root-causes-and-monitoring/]]></link>
			<title>Capsule Fill Weight Variation: Root Causes and Monitoring</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/coating-process-validation-weight-gain-and-defect-control/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/coating-process-validation-weight-gain-and-defect-control/]]></link>
			<title>Coating Process Validation: Weight Gain and Defect Control</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tablet-hardness-and-friability-inprocess-control-strategy/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tablet-hardness-and-friability-inprocess-control-strategy/]]></link>
			<title>Tablet Hardness and Friability: In-Process Control Strategy</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/blend-uniformity-sampling-stratification-and-analytical-variability/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/blend-uniformity-sampling-stratification-and-analytical-variability/]]></link>
			<title>Blend Uniformity Sampling: Stratification and Analytical Variability</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/fluid-bed-drying-end-point-moisture-and-process-controls/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/fluid-bed-drying-end-point-moisture-and-process-controls/]]></link>
			<title>Fluid Bed Drying End Point: Moisture and Process Controls</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/granulation-end-point-determination-torque-and-moisture/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/granulation-end-point-determination-torque-and-moisture/]]></link>
			<title>Granulation End Point Determination: Torque and Moisture</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tablet-compression-defects-capping-lamination-and-sticking/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tablet-compression-defects-capping-lamination-and-sticking/]]></link>
			<title>Tablet Compression Defects: Capping, Lamination and Sticking</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/pharmaceutical-label-inspection-vision-systems-and-challenge-sets/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/pharmaceutical-label-inspection-vision-systems-and-challenge-sets/]]></link>
			<title>Pharmaceutical Label Inspection: Vision Systems and Challenge Sets</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/temperature-data-logger-qualification-for-pharma-shipments/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/temperature-data-logger-qualification-for-pharma-shipments/]]></link>
			<title>Temperature Data Logger Qualification for Pharma Shipments</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/cold-chain-shipping-qualification-lane-risk-and-temperature-mapping/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/cold-chain-shipping-qualification-lane-risk-and-temperature-mapping/]]></link>
			<title>Cold Chain Shipping Qualification: Lane Risk and Temperature Mapping</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/packaging-artwork-change-control-proofreading-and-approval/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/packaging-artwork-change-control-proofreading-and-approval/]]></link>
			<title>Packaging Artwork Change Control: Proofreading and Approval</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tamperevident-packaging-design-and-inspection-controls/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/tamperevident-packaging-design-and-inspection-controls/]]></link>
			<title>Tamper-Evident Packaging: Design and Inspection Controls</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/serialization-in-pharmaceutical-packaging-data-and-verification/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/serialization-in-pharmaceutical-packaging-data-and-verification/]]></link>
			<title>Serialization in Pharmaceutical Packaging: Data and Verification</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/printed-packaging-component-reconciliation-labels-and-cartons/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/printed-packaging-component-reconciliation-labels-and-cartons/]]></link>
			<title>Printed Packaging Component Reconciliation: Labels and Cartons</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/packaging-line-clearance-preventing-product-mixups/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/packaging-line-clearance-preventing-product-mixups/]]></link>
			<title>Packaging Line Clearance: Preventing Product Mix-Ups</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/container-closure-integrity-testing-for-sterile-vials/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/container-closure-integrity-testing-for-sterile-vials/]]></link>
			<title>Container Closure Integrity Testing for Sterile Vials</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 03:00:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/blister-pack-leak-testing-dye-ingress-and-vacuum-decay/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/blister-pack-leak-testing-dye-ingress-and-vacuum-decay/]]></link>
			<title>Blister Pack Leak Testing: Dye Ingress and Vacuum Decay</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:59:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/gmp-user-access-reviews-role-design-and-segregation-of-duties/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/gmp-user-access-reviews-role-design-and-segregation-of-duties/]]></link>
			<title>GMP User Access Reviews: Role Design and Segregation of Duties</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/spreadsheet-formula-verification-independent-checks-and-protection/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/spreadsheet-formula-verification-independent-checks-and-protection/]]></link>
			<title>Spreadsheet Formula Verification: Independent Checks and Protection</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/disaster-recovery-for-gmp-laboratories-recovery-objectives-and-tests/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/disaster-recovery-for-gmp-laboratories-recovery-objectives-and-tests/]]></link>
			<title>Disaster Recovery for GMP Laboratories: Recovery Objectives and Tests</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/periodic-review-of-gmp-computerised-systems-evidence-and-triggers/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/periodic-review-of-gmp-computerised-systems-evidence-and-triggers/]]></link>
			<title>Periodic Review of GMP Computerised Systems: Evidence and Triggers</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/change-control-for-computerised-systems-regression-testing/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/change-control-for-computerised-systems-regression-testing/]]></link>
			<title>Change Control for Computerised Systems: Regression Testing</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/laboratory-information-management-systems-sample-lifecycle-controls/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/2026/11/16/laboratory-information-management-systems-sample-lifecycle-controls/]]></link>
			<title>Laboratory Information Management Systems: Sample Lifecycle Controls</title>
			<pubDate><![CDATA[Mon, 16 Nov 2026 02:57:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Mon, 02 Nov 2026 09:37:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaguidelines.co.uk/articles/]]></guid>
			<link><![CDATA[https://pharmaguidelines.co.uk/articles/]]></link>
			<title>Articles</title>
			<pubDate><![CDATA[Sun, 01 Nov 2026 02:36:06 +0000]]></pubDate>
		</item>
				</channel>
</rss>
